KMT2A and leukemia: Intriguingly, and in contrast to the global dogma of cancer biology, MLL-r infant leukemia has been shown to have abnormal hypermethylation in non-enhancer, non-promoter regions, perhaps contributing to genomic stability and a silenced mutational landscape [76,81,82].